Skip to main content
. 2012 Jul 1;6(4):780–785. doi: 10.1177/193229681200600407

Figure 2.

Figure 2

Postprandial glucose change from baseline in the meal tolerance test protocol with and without the application of the InsuPatch device in subjects with type 1 diabetes mellitus using continuous subcutaneous insulin infusion therapy (N = 17).